Mark A. Goldstein

Internal Medicine
132 Moorings Park Dr
Naples, FL 34105

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Evaluation of c-Abl inhibitor vodobatinib in subjects with early Parkinson's disease: a phase 2, randomized, double-blind, placebo-controlled study.

Evaluation of c-Abl inhibitor vodobatinib in subjects with early Parkinson's disease: a phase 2, randomized, double-blind, placebo-controlled study.

Journal: NPJ Parkinson's disease
Published: July 11, 2025
Showing 1-1 of 1

Last Updated: 09/26/2026